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The genetic defect of mdx mice resembles that of Duchenne muscular dystrophy, although their functional performance and life
expectancy is nearly normal. By contrast, mice lacking utrophin and dystrophin (mdx/utrn /) are severely aﬀected and die prema-
turely. Mice with one utrophin allele (mdx/utrn +/) are more severely aﬀected than mdx mice, but outlive mdx/utrn / mice. We sub-
jected mdx/utrn +/+, +/, / and wild type males to a 12 week functional test regime of four diﬀerent functional tests. Mdx/utrn +/+
and +/mice completed the regime, while mdx/utrn /mice died prematurely.Mdx/utrn +/mice performed signiﬁcantly worse com-
pared to mdx/utrn +/+ mice in functional tests. Creatine kinase levels, percentage of ﬁbrotic/necrotic tissue, morphology of neuromus-
cular synapses and expression of biomarker genes were comparable, whereas mdx/utrn +/ and / mice had increased levels of
regenerating ﬁbers. This makes mdx/utrn +/ mice valuable for testing the beneﬁt of potential therapies on muscle function parameters.
 2011 Elsevier B.V.
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Duchenne muscular dystrophy (DMD) is an X-linked,
severe, muscle wasting neuromuscular disorder leading to
death in the early thirties in theWestern world. Due to frame
shifting or nonsense mutations in theDMD gene, truncated,
non functional dystrophin proteins are synthesised. Intact
dystrophin is part of the dystrophin–associated protein
complex that connects the extracellular matrix to the
cytoskeleton thereby providing muscle ﬁbers with stability
during contraction. In the absence of dystrophin, ﬁbers are
more injury-susceptible and eventually the regenerative0960-8966  2011 Elsevier B.V.
doi:10.1016/j.nmd.2011.10.011
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Open access under the Elsevier OA license.capacity of the ﬁbers becomes exhausted resulting in the
replacement by connective and adipose tissue [1].
The mdx mouse, which carries a nonsense mutation in
exon 23 of the mouse Dmd gene, is the most commonly
used mouse strain for DMD research. Despite the resem-
bling genetic defects, their functional performance and life
expectancy is nearly normal, which is thought to result
from a combination of improved regeneration, upregula-
tion of muscle transcription factors like myoD and func-
tional compensation by upregulation of the dystrophin
homologue utrophin [2,3].
During development, utrophin is predominantly found
at the sarcolemma of developing and regenerating ﬁbers
before dystrophin is expressed [4]. In mature muscle ﬁbers,
dystrophin replaces utrophin, which is in this phase only
present at the neuromuscular junction (NMJ) where it co-
localizes with acetylcholine receptors and is involved in
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receptor clustering [5,6]. In DMD patients, female DMD-
carriers and the mdx mouse, the expression of utrophin at
the extra-synaptic sarcolemma is dramatically increased in
dystrophin negative ﬁbers [7,8]. In mdx mice, muscles with
the greatest upregulation of utrophin exhibit the least path-
ological changes and are most resistant to injury [9]. Also in
DMD patients, a negative correlation between utrophin
upregulation and disease severity has been described [8].
Moreover, overexpression of a truncated or full length utro-
phin in mdx mice improves dystrophic pathology in a utro-
phin concentration dependent manner [3,9–12]. Mice
lacking only one or both utrophin alleles are viable and fer-
tile and display only a mild (subclinical) congenital myas-
thenia, which was concluded to result from eﬀective
replacement of utrophin by dystrophin at the NMJ
[13,14]. By contrast, mice deﬁcient for both dystrophin
and utrophin (mdx/utrn /) are severely aﬀected, develop
pronounced scoliosis and kyphosis, have impaired mobility,
diﬃculty breathing and a reduced life expectancy of around
3 months, thus more closely resembling the DMD patient
phenotype [13,14]. Unfortunately, sincemdx/utrn/mice
are short lived and diﬃcult to breed and maintain, they are
not an ideal animal model for the study of long term eﬀects
of potential therapeutic compounds. In addition, on a histo-
logical level, mdx/utrn / mice are comparable to mdx
mice, possibly because they do not live long enough to
develop a more severe dystrophic and/or ﬁbrotic phenotype
[13]. Mdx mice with haploinsuﬃciency of the utrn gene
(mdx/utrn +/) have an almost normal life span, but show
more pronounced skeletal inﬂammation and ﬁbrosis at an
age of 3 and 6 months, respectively [15]. At 6 months of
age, they also show a more severe impaired respiratory
function and ﬁbrosis of the diaphragm than mdx mice
[16]. This suggests that the functional compensation of dys-
trophin by utrophin is incomplete when expressed in a het-
erozygous manner in mdx mice.
To assess how heterozygous expression of utrophin in
mdx mice aﬀects disease progression, muscle function and
histology, mdx/utrn /, mdx/utrn +/, mdx/utrn +/+
andC57BL/10ScSnJ (wild type)micewere subjected to apre-
viously developed 12 week functional test regime addressing
strength and coordination of diﬀerent muscle groups [17].
We show here thatmdx/utrn+/mice perform signiﬁcantly
worse than mdx/utrn +/+ mice, while levels of ﬁbrosis and
mRNA biomarkers are comparable at 4 months of age. We
propose that the mdx/utrn +/ model is a more suitable
mouse model for testing potential therapies for DMD.
2. Materials and methods
2.1. Animal care
All studied mouse strains were bred at the animal facility
of the LUMC where they were housed in individually ven-
tilated cages with 12-h light–dark cycles. Mice were given
standard chow and water ad libitum. Breeding pairs ofmdx mice heterozygous for a utrophin knockout mutation
(mdx/utrn +/) gave birth to mdx mice with two (mdx/utrn
+/+), one (mdx/utrn +/) and zero (mdx/utrn /) utro-
phin alleles. Genotyping was performed on DNA obtained
from tail tips by PCR analysis (primers and PCR condition
on request). All experiments were approved by the Animal
Experimental Committee (DEC) of the LUMC.2.2. Functional tests
Four week old male mdx/utrn +/+, +/, / and
C57BL/10ScSnJ mice (n = 6 per group) were subjected to
a 12 week functional test regime consisting of four diﬀerent
functional tests, each addressing diﬀerent muscle groups
and/or coordination [17]. Mice performed the tests in the
afternoon on consecutive days on a weekly basis. Body
weight was assessed at the beginning and end of each week.
Where possible, standard operating procedures from the
TREAT-NMD network were implemented (http://www.
treat-nmd.eu/resources/research-resources/dmd-sops/).
2.3. Fore limb grip strength test
Fore limb grip strength was assessed by means of a grip
strength meter (Columbus Instruments, USA). Mice were
suspended above a grid which they instinctively grasped.
Mice were then pulled backwards so that they released
the grid. This was repeated ﬁve times in a row. The average
of the three highest measured values was used to calculate
the absolute strength, which was divided by the body
weight in grams to obtain the normalized strength.
2.4. Rotarod
Mice were placed on the Rotarod (Ugo Basile, Italy)
that accelerated from 5 to 45 rotations per minute within
15 s. The test session ended when a mouse ran for 500 s
without falling. Two more tries were given to mice that fell
oﬀ within 500 s. The longest running time was used in all
analyses.
2.5. Two limb hanging wire test
Mice were suspended above a metal cloth hanger which
was secured above a cage with bedding and released a few
seconds after instinctively grasping the wire with the fore
limbs. Depending on the functional ability of the mouse,
all limbs and the tail were used during a 10 min hanging
session. Mice that fell down before the 10 min time limit
were given two more tries. The longest hanging time was
used for further analysis.
2.6. Four limb hanging wire test
The start position of this test was with all four limbs. To
this end, mice were placed on a grid, which was then turned
408 M. van Putten et al. / Neuromuscular Disorders 22 (2012) 406–417upside down above a cage ﬁlled with bedding. The session
ended after a hanging time of 10 min was achieved or
otherwise after three sessions. The maximum hanging time
was used for further analysis.
2.7. Creatine kinase level analysis
Blood was collected weekly on Monday mornings via a
small cut at the end of the tail in a Minicollect tube (0.8 ml
Lithium Heparin Sep, Greiner bio-one, Austria). Creatine
kinase (CK) levels were determined in plasma with Reﬂo-
tron CK test strips in the Reﬂotron plus machine (Roche
diagnostics Ltd., UK).
2.8. Histological examination
After performing the functional test regime for
12 weeks, mice (aged 16 weeks) were euthanized by cervical
dislocation and the tibialis anterior, triceps and quadriceps
were dissected and snap frozen in 2-methylbutane (Sigma–
Aldrich, The Netherlands) cooled in liquid nitrogen. Sec-
tions of 8 lm were cut on Superfrost Plus slides (Thermo
Fishes Scientiﬁc, Menzel-Gla¨ser, Germany) with a Shan-
don cryotome (Thermo Fisher Scientiﬁc Co., Pittsburgh,
PA, USA) along the entire length of the muscle with an
interval of 240 lm between the sections. The excess tissue
belonging to the 240 lm intervals was collected in MagNa
Lyser Green Beads tubes (Roche diagnostics Ltd., UK) for
total RNA isolation. Sections were ﬁxed for 5 min with ice-
cold acetone and stained with Harris Haematoxylin and
Eosin (H&E) (Sigma–Aldrich, The Netherlands) according
to conventional histological procedures. Sections were
examined with a light microscope (Leica DM LB, Leica
Microsystems, The Netherlands) at a 5 magniﬁcation
and images were captured with a Leica DC500 camera
and Leica IM50 software (Leica Microsystems, The Neth-
erlands) from the middle section of the muscles. Blending
and background correction was performed with Adobe
Photoshop CS3 version 10.0.1. Freely available ImageJ
software with the H&E color deconvolution plugin (Ras-
band, W.S., ImageJ, U. S. National Institutes of Health,
Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/)
was used to determine the ﬁbrotic/necrotic percentage of
the entire cross section by two individuals in a double
blinded manner, as described previously [17].
Fiber size and the proportion of centrally nucleated
ﬁbers were determined with Mayachitra Imago 1 (http://
www.mayachitra.com/imago/) on whole muscle cross sec-
tions of the tibialis anterior. Sections were stained with a
laminin antibody, (ab11575, dilution 1:50, Abcam, USA),
goat-anti-rabbit Alexa 594 (dilution 1:1000, Invitrogen,
The Netherlands) and DAPI. Sections were examined
and the middle section of the muscle was captured with a
ﬂuorescent microscope (Leica DM 5500B) and a Snapshot
camera (Photometrics Coolsnap K4) at a 5 magniﬁca-
tion. Images were mozaiked with the Mayachitra Imago
1 (http://www.mayachitra.com/imago/) and preprocessedwith ImageJ to obtain an even illumination of laminin. Pic-
tures were segmented by the Mayachitra Imago software
based on the staining intensity diﬀerence between the mem-
branes and the cytoplasm. Of these segmented ﬁbers, the
area (lm2), ﬁber density and the percentage of central
nucleation were determined. Fibers were assessed for pres-
ence of centralized nuclei based on the maximum intensity
(from the blue channel) of the cytoplasm. Objects smaller
than 200 lm2 were excluded from analysis. Fiber density
was determined by dividing the total number of ﬁbers by
the total area of the cross section.
Utrophin and dystrophin expression was analyzed for the
quadriceps stained with utrophin (MANCHO7, dilution
1:50, Santa Cruz, Germany), dystrophin (C-20, dilution
1:50, Santa Cruz, Germany), donkey-anti-goat Alexa 594
(dilution 1:1000, Invitrogen, The Netherlands) and DAPI
with use of the mouse on mouse (MOM) kit (Vector
Laboratories, UK). Sections were examined with a ﬂuores-
cent microscope (Leica DM RA2) at a 16 magniﬁcation
and captured with a Leica DC350FX Snapshot camera.
Morphology of the NMJ was assessed on whole-mount
diaphragm muscles of two mice per genotype. The snap-
frozen diaphragm was thawed in PBS, pinned out on a
silicone-rubber lined Petri dish and ﬁxated with 1% para-
formaldehyde in PBS for 30 min after it was washed with
PBS (30 min). Incubation with Alexa Fluor 488 a-bungaro-
toxin (1 lg/ml, Molecular Probes, The Netherlands) lasted
2.5 h and was followed by PBS washing (30 min). All incu-
bations were performed at room temperature (20–22 C).
Muscle strips were mounted with Citiﬂuor AF-1 (Citiﬂuor
Ltd., UK) and covered with a cover slip which was secured
with nail polish. Slides were examined with an Axioskop
2FS microscope equipped with ﬂuorescence optics (Zeiss,
Jena, Germany) at a 400 magniﬁcation and pictures were
taken using Zeiss Axiovision [18].
2.9. Western blot analysis
Muscles were homogenized using treatment buﬀer
(100 mM Tris–HCl pH 6.8 and 25% SDS) using MagNa
Lyser green beads in the MagNa Lyser (Roche Diagnos-
tics, The Netherlands). Protein concentration was deter-
mined with the BCA protein assay kit (Thermoscientiﬁc,
IL, USA), according to the manufacturer’s instructions.
Subsequently, the homogenate was complemented to con-
tain 75 mM Tris–HCl pH 6.8, 15% SDS, 5% b-mercap-
toethanol, 20% glycerol and 0.001% bromophenol blue.
Samples (50 lg) were boiled for 5 min and 75 ll was loaded
on a 4–7% gradient polyacrylamide gel and run overnight
at 4 C. Gels were blotted to nitrocellulose BA83 (What-
man, Schleicher & Schuell, Germany) for 6 h at 4 C and
blocked with 5% non-fat dried milk (Campina Melkunie,
The Netherlands) in TBS. Primary utrophin antibody
8A4 (dilution 1:100, Santa Cruz, Germany) was incubated
over night at 4 C. The ﬂuorescent IRDye 800CW goat-
anti-mouse IgG (dilution 1:5000, Li-Cor, NE, USA) was
used as a secondary antibody. Blots were visualized and
Fig. 1. Survival, body weight and plasma CK levels of the diﬀerent mouse
strains over time. (A) Survival curve of the mdx/utrn / mice. All mice
died before the age of 10 weeks. (B) Body weight of mdx/utrn / mice
was signiﬁcantly lower than that of all other mouse strains.Mdx/utrn +/
mice were signiﬁcantly heavier than mdx/utrn +/+ and wild type mice. (C)
CK levels of the wild type mice were signiﬁcantly lower (<500 U/L) when
compared to the three dystrophic mouse strains, which did not diﬀer
among themselves. Data represent the mean and standard deviation per
time point.
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NE, USA) as described previously [19].
2.10. Biomarker analysis
cDNA was synthesised from 1 lg of total RNA with
random hexamer primers and expression levels of genes
involved in regeneration (Myog, Myh3), inﬂammation
(Lgals3, Cd68) and ﬁbrosis (Col1a1, Lox) were determined
by Sybr Green based Real Time qPCR (95 C 10 s, 60 C
30 s, 72 C 20 s, 45 cycles followed by melting curve analy-
sis) on the Roche Lightcycler 480 (Roche diagnostics Ltd.,
UK). Gapdh was used as a reference gene, since the expres-
sion of this gene did not diﬀer between diﬀerent strains, dif-
ferent muscles or over time. Primer eﬃciencies were
determined and analysis was performed with LinREgPCR
version 11.1 [20]. The average expression levels of C57BL/
10ScSnJ mice were set to one.
2.11. Statistics
Statistical analyses were performed with statistical soft-
ware in R (version R2.11.1). Figs. 1 and 2 summarize the
data, i.e. showing the mean and standard deviation per
genotype and age. To overcome applying separate tests
for each age between genotypes, which suﬀers from multi-
ple testing and ignores the age trend, we applied an analysis
of covariance (ANCOVA) to the data. ANCOVA was
applied to temporal functional performance, body weight
and CK level data with age as continuous and genotype
as a categorical variable. In choosing the appropriate
model we applied the principle of parsimony. Given the
application of tests for several diﬀerent variables, we con-
sidered P < 0.01 as signiﬁcant.
The two-tailed homoscedastic Student’s t-test was con-
ducted for comparison of the single time point histological
and gene expression data. P < 0.05 was used to determine
signiﬁcance for the histopathology, while P < 0.01 was used
for the gene expression data to correct for multiple testing.
3. Results
3.1. Functional tests
Four week old male mdx/utrn +/+, mdx/utrn +/, mdx/
utrn / and wild type mice followed a 12 week functional
test regime consisting of four diﬀerent functional tests on
consecutive days on a weekly basis [17]. The test regime
consisted of fore limb grip strength, rotarod running and
two and four limb hanging wire tests. Mdx/utrn / mice
were humanely sacriﬁced when their body weight had
dropped >15% within 2 days, which was the case between
6 and 9 weeks of age for all mice (Fig. 1A). All mdx/utrn
/ developed severe kyphosis and showed diﬃculties
moving and breathing. Once a week, body weight and
plasma CK levels were assessed. When body weight was
compared between groups over time, mdx/utrn / micewere signiﬁcantly (P < 0.01) lighter compared to the other
strains (Fig. 1B). By contrast, mdx/utrn +/ mice were sig-
niﬁcantly (P < 0.01) heavier than both mdx/utrn +/+ and
wild type mice. Plasma CK levels were signiﬁcantly
(P < 0.01) elevated for all mouse strains compared to wild
type (<500 U/L), but no diﬀerences were found between
the dystrophic strains (Fig. 1C).
Wild type mice outperformed (P < 0.01) all the dystro-
phic mouse strains in the fore limb grip strength test with
an average normalized fore limb strength of 5.4. No diﬀer-
ence was observed between the mdx/utrn +/+, +/ and /
 mice ((5.0, 4.9, 4.2, respectively) Fig. 2A). On the rota-
rod, the wild type mice ran, with an average highest
Fig. 2. Functional test performance of the diﬀerent mouse strains over the 12 week functional test regime. (A) Normalized grip strength was signiﬁcantly
higher in wild type mice when compared to the dystrophic mouse strains, but did not diﬀer between them. (B) Rotarod running times of wild type mice
were signiﬁcantly longer (224 s) than that of mdx/utrn +/+ mice. From an age of 10 weeks, mdx/utrn +/ mice ran signiﬁcantly shorter (77 s) than mdx/
utrn +/+ mice (140 s), but running times did not diﬀer from mdx/utrn / mice. (C) Two limb hanging wire performance was best for wild type and mdx/
utrn +/+ mice. Mdx/utrn +/ and / performed signiﬁcantly worse. (D) In the four limb hanging wire test, wild type and mdx/utrn +/+ mice had a
signiﬁcantly longer hanging time than mdx/utrn +/ mice. For all mice except for the mdx/utrn / mice maximum hanging time was longer in the two
limb hanging tests than the four limb hanging test (compare C versus D). Data represent the mean and standard deviation per time point.
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the other strains. Up to an age of 10 weeks, no diﬀerence
between the dystrophic mouse strains was observed. How-
ever, from 11 weeks on, running times for mdx/utrn +/+
increased and mice ran signiﬁcantly (P < 0.01) longer
(140 s) than age-matched mdx/utrn +/ mice (average
77 s), which performance did not increase and remained
as poor as the mdx/utrn / mice did when they were still
alive (Fig. 2B). For the hanging wire tests the maximum
hanging time was used as outcome measure which did
not diﬀer between wild type and mdx/utrn +/+ mice for
both the two and four limb hanging wire tests (Fig. 2C
and D).Mdx/utrn +/mice hang for a signiﬁcantly shorter
time period of 141 and 135 s, for the two and the four limb
hanging test, respectively. The two limb hanging test per-
formance of the mdx/utrn / mice was as bad as that
of the mdx/utrn +/ mice, whereas they performed better
in the four limb hanging test. This is because of the survival
of only the good performing mice.
3.2. Histological examination
After the mice completed the 12 week functional test
regime, they were sacriﬁced and skeletal muscles were iso-
lated. Cryosections of the quadriceps stained for utrophinand dystrophin showed a strong dystrophin staining in
the wild type mice, whereas utrophin staining was weak.
By contrast, ﬁbers were clearly utrophin positive in the
mdx/utrn +/+ and +/ mice (Fig. 3A). As anticipated,
mdx/utrn / mice lacked both dystrophin and utrophin.
These results were conﬁrmed by Western Blot analysis,
which showed an upregulation of utrophin in mdx/utrn
+/+ mice and to a lesser extent in the mdx/utrn +/ mice
of approximately 2.2- and 1.8-fold, respectively (Fig. 3B).
The percentage of ﬁbrotic/necrotic tissue was assessed in
all mouse strains for the tibialis anterior, triceps and quad-
riceps on H&E stained complete cross sections obtained
from the middle part of the muscle. The proportion of
ﬁbrosis, necrosis, connective tissue and freshly regenerated
tissue was determined with a color deconvolution plugin of
Image J as described previously [17]. Wild type mice had
signiﬁcantly less ﬁbrotic/necrotic tissue (2%) than the
dystrophic mouse strains, for which the histopathological
severity did not signiﬁcantly diﬀer between the strains
and varied between 8% and 13% for the diﬀerent muscles
(Fig. 4A–C). Only for the quadriceps, a signiﬁcant diﬀer-
ence (P < 0.05) between mice with 1 and 0 utrophin alleles
was observed.
Fiber size distribution, ﬁber density and the percentage of
centralized nuclei was determined on the middle section of
Fig. 3. Utrophin and dystrophin immunostaining and Western blot analysis of the quadriceps. (A) Fibers of wild type mice expressed dystrophin whereas
utrophin was hardly detectable. Fibers of mdx/utrn +/+ and +/ mice were strongly positive for utrophin staining, while dystrophin staining was
negative. In mdx/utrn / mice, ﬁbers were negative for both utrophin and dystrophin. (B) Utrophin Western blot of the quadriceps. Utrophin was
upregulated in both mdx/utrn +/+ and +/ mice, but to a larger extent for mdx/utrn +/+ mice. Each lane represents an individual mouseMdx/utrn /
mice did not express utrophin. Scale marker is 64 lm.
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were automatically analyzed with Mayachitra Imago which
segmented the image and deﬁned ﬁber area based on the
number of pixels within an object and centralized nuclei
based on the maximum intensity of ﬁbers (Fig. 4D and E).
The percentage of centrally nucleated ﬁbers was 2% in wild
type mice, while it was over 50% in the dystrophic mouse
strains. A clear trend was observed, in which the number
of utrophin alleles of the mice correlated to the number of
centrally nucleated ﬁbers, which reached signiﬁcance when
comparing mice with two or zero utrophin alleles. In line
with this trend, we also observed a higher number of small
regenerated ﬁbers (<1000 lm2) in the more severely aﬀected
mdx/utrn +/ and / mice. No hypertrophic ﬁbers were
observed for the mdx/utrn / mice, while they were pres-ent in the sections of the mdx/utrn +/mice and to a bigger
extent in mdx/utrn +/+ mice. The ﬁber size distribution of
the mdx/utrn +/+ mice matched that of the wild type mice
more than those of the mdx/utrn +/ and /
mice. Fiber density (number of ﬁbers per lm2) was deter-
mined for all mice by dividing the total number of ﬁbers
by the total area of the whole cross section. We observed
no signiﬁcant diﬀerence between any of the mouse strains
(Fig. 4F). Since mdx mice are known to have hypertrophic
muscle and we observed that mdx/utrn +/ mice also have
hypertrophic muscle to some extent, their muscle mass to
body weight (muscle mass divided by body weight) of the
quadriceps and gastrocnemius was compared (n = 4–6).
Muscle mass to body weight ratio of mdx/utrn +/+ mice
(quadriceps mean 0.0080, SD 0.0009 and gastrocnemius
Fig. 4. Percentage of ﬁbrotic/necrotic area, central nucleation, ﬁber size and density. (A–C) For the tibialis anterior and triceps no signiﬁcant diﬀerence in
the percentage of ﬁbrosis/necrosis was observed between the dystrophic mouse strains. In the quadriceps, the level signiﬁcantly diﬀered between mdx/utrn
+/ and / mice. The levels in the wild type mice were signiﬁcantly lower (P < 0.05) than the other mouse strains as indicated by the #. Single asterisks
indicate a P < 0.05. (D–E) The ﬁber size and percentage of central nucleation was automatically determined with Mayachitra Imago, which segments the
ﬁbers into individual objects. Based on the maximum intensity (from the blue channel) of the cytoplasm, ﬁbers were assessed for presence of centralized
nuclei. The percentage of centralized nuclei was signiﬁcantly increased in the dystrophic mouse strains compared to the wild type. The mdx/utrn / mice
had signiﬁcantly more central nucleated ﬁbers than the mdx/utrn +/+ mice. (E) Especially the mdx/utrn +/ and / mice had a large number of small
regenerated ﬁbers (<1000 lm2). No hypertrophic ﬁbers were found in the mdx/utrn / mice. (F) Fiber density was comparable between wild type, mdx/
utrn +/+ and +/ mice. Signiﬁcantly higher densities were observed in the mdx/utrn / mice, which corresponds to the high number of small
regenerated ﬁbers found in these mice.
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that of mdx/utrn +/ mice (quadriceps mean 0.0081, SD
0.0016 and gastrocnemius mean 0.0062, SD 0.0011) as was
previously reported [13]. It should be noted, however, that
the mdx/utrn +/ mice were signiﬁcantly heavier than the
mdx/utrn +/+ mice.To qualitatively assess the eﬀect of expression of one,
two or zero utrophin alleles in mdx mice on the morphol-
ogy of NMJs, the diaphragm of two mice per genotype
was stained with Alexa Fluor 488 a-bungarotoxin and
viewed with ﬂuorescence microscopy (Fig. 5). NMJs of
wild type mice generally had continuous branches of ace-
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mouse strains showed discontinuous, more punctuate
staining [14,21–23]. This punctuate pattern was observed
to more or less equal extent in all dystrophic genotypes,
the current quantitative analysis not allowing to discrimi-
nate amongst them.3.3. Biomarker analysis
The expression of some potential biomarker genes
known to be involved in diﬀerent pathological processes
was determined in the quadriceps of mice of the four strains
that underwent the functional test regime. For each gene,
expression was upregulated in the three dystrophic mouse
strains compared to wild type levels (Fig. 6). In concor-
dance with the histological analysis, no signiﬁcant diﬀerenceFig. 5. Diaphragm NMJs stained with Alexa Fluor 488 a-bungarotoxin, which
diﬀerent mice per genotype. Clear distinctions in morphology are visible betwe
intact and show continuous acetylcholine receptor area branches that are arran
had a more disorganized, punctuate structure with discontinuous branches, w
mice. Scale marker is 20 lm.was observed between mdx/utrn +/+ and +/ mice,
although a trend of higher levels in the mdx/utrn +/ mice
was found. Themdx/utrn/ levels were increased or com-
parable to mdx/utrn +/ levels. As the mdx/utrn / mice
were younger than the other strains (8–9 weeks versus
16 weeks) due to their premature death, we also checked
the expression levels in the gastrocnemius of 6 week old
mice for the four strains, to exclude that the observed diﬀer-
ences were age related. Also in these young mice, a signiﬁ-
cant lower expression was found in wild type mice than in
the dystrophic mouse strains. Between the dystrophic mice,
a clear disease severity-related trend was observed for all
genes, except forCol1a1, with themdx/utrn/mice show-
ing the highest levels, followed by mdx/utrn +/ and mdx/
utrn+/+mice. For Lgals3 andMyh3 the diﬀerence between
mdx/utrn +/+ and / mice reached signiﬁcance.labels acetylcholine receptors. Representative pictures of synapses of two
en wild type and dystrophic mice. The majority of wild type synapses are
ged in an elliptical manner. Most synapses of the dystrophic mouse strains
ith apparent qualitative similarity between mdx/utrn +/+, +/ and /
Fig. 6. Biomarker gene expression in 16 and 6 weeks old mice. (A and B) Expression of genes involved in regeneration (Myog, Myh3), inﬂammation
(Lgals3, Cd68) and ﬁbrosis (Col1a1, Lox) was elevated in 16 weeks old mdx/utrn +/ mice compared to the other mouse strains. Note that the mdx/utrn
/ mice were sacriﬁced between the age of 6 and 9 weeks as a consequence of their severe phenotype. (C and D) For all genes in the age-matched mice,
the expression level was the highest in mdx/utrn / mice, followed by the mdx/utrn +/ and the +/+ mice. Expression values shown have been
normalized with Gapdh expression and are shown relative to wildtype values.
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Pre-clinical research on DMD pathology and the devel-
opment of potential therapies has primarily made use of
the mdx mouse, which resembles the genetic defect found
in DMD patients [24]. Unfortunately, since the mdx
mouse’s functional ability and lifespan is only slightly
reduced and none of the skeletal muscles except the dia-
phragm show severe histopathology, the mouse does not
resemble the pathology observed in DMD patients. One
of the underlying causes of the improved phenotype is
upregulation of utrophin which is less pronounced in
patients than it is in mdx mice. The mdx/utrn / mouse
more closely resembles the natural history of the disease
with their short life span, kyphosis and walking diﬃculties
[13]. Unfortunately, their fragility and limited life expec-
tancy prevents long term treatment studies in these mice.
With pre-clinical research focussing on the eﬀect of poten-
tial therapeutic compounds on functional performance and
ﬁber integrity, a mouse model more severely aﬀected than
the mdx mouse, but with a longer lifespan than the mdx/
utrn / mouse would be very helpful.
In this study, we tested how mono-allelic expression of
utrophin aﬀects muscle function, histopathology and dis-
ease progression.Mdx mice with two, one or zero utrophinalleles were subjected to a 12 week functional test regime.
The performance of mdx/utrn +/ mice in the functional
tests was as bad as that of mdx/utrn / mice and signif-
icantly worse than that of mdx/utrn +/+ and wild type
mice for rotarod and two and four limb hanging wire tests.
Since the performance of the mdx/utrn +/+ mice closely
matched that of wild type mice, assessing functional
improvement in mdx/utrn +/+ mice upon treatment is
challenging. Using the functionally more hampered mdx/
utrn +/ mouse would enable better monitoring of func-
tional improvement upon treatment. Only grip strength
did not diﬀer between mdx/utrn +/ and +/+ mice. Perfor-
mance of mdx/utrn +/+ mice matched that of C57BL/
10ScSnJ-DMDmdx/J mice (i.e. mdx mice on a pure BL10
background) tested with the same functional test regime
[17]. An exception was the rotarod performance where
C57BL/10ScSnJ-DMDmdx/J mice peaked at an age of
7 weeks, while mdx/utrn +/+ mice did not. This might
result from the diﬀerence in background between the two
strains, an observation which has been described previ-
ously for grip strength performance of two wild type strains
[25]. For the four limb hanging wire test, mdx/utrn /
mice even outperformed the mdx/utrn +/ mice, but this
is caused by the survival of only the mouse which per-
formed best in this test, while the mice that did not perform
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mdx/utrn / mice is in line with previous ﬁndings of
lower twitch and tetanus force, which is observed to a
lower extent in mdx/utrn +/+ mice [26]. No diﬀerences in
CK levels between the dystrophic strains were observed
over time but levels were signiﬁcantly elevated for the dys-
trophic mouse strains compared to wild type as expected.
When strains are compared for over half a year, mdx/utrn
+/ mice have signiﬁcantly higher CK levels than mdx
mice (Tanganyika – de Winter et al., submitted for
publication).
Histopathology did not diﬀer in severity between the
three dystrophic mouse strains at an age of 4 months. This
is in concordance with Zhou et al., who observed no diﬀer-
ence in Collagen III immunostaining in quadriceps between
mdx and mdx/utrn +/ mice aged 3 months [15]. Histopa-
thology is known to increase in severity over time, as indi-
cated by more pronounced ﬁbrosis in 6 months old mdx/
utrn +/ compared to mdx mice. The mdx/utrn / mice
did have a signiﬁcantly lower percentage of ﬁbrotic/necrotic
tissue in the quadriceps than the mdx/utrn +/ mice. The
number of centrally nucleated ﬁbers was increased in the
mdx/utrn +/ and / compared to the mdx/utrn +/+
and wild type mice. The signiﬁcant diﬀerence observed
betweenmdx/utrn+/+ and/ is in concordance with pre-
vious published work [27]. The high number of ﬁbers with
central nuclei observed in the mdx/utrn +/ and / mice
nicely overlaps with that of small regenerated ﬁbers in these
mice. This indicates that the regeneration can still keep up
in these more severe mice, which is in contrast to DMD
patients, which usually have a lower regenerative capacity.
Fiber density was signiﬁcantly higher inmdx/utrn/ com-
pared to mdx/utrn +/+ and +/ mice, which corresponds
to their high number of regenerated and low number of
hypertrophic ﬁbers. No signiﬁcant diﬀerence was found
between mdx/utrn +/+ and +/ mice, although ﬁber den-
sity was slightly lower inmdx/utrn+/+mice. This slight dif-
ference is caused by the large proportion of hypertrophic
ﬁbers of the mdx/utrn +/+ that exceeded that of mdx/utrn
+/ and wild type mice. On the other hand, the proportion
of small regenerated ﬁbers of mdx/utrn +/ exceeded that
of mdx/utrn +/+ and wild type mice. Hypertrophy was
not observed in the mdx/utrn / mice, which might be
due to their short lifespan, during which damaged ﬁbers
are continuously replaced by newly regenerated ﬁbers.
Muscle mass to body weight ratio showed no signiﬁcant
diﬀerence between mdx/utrn +/+ and +/ mice. Previ-
ously, a similar comparison has been made between mdx
and mdx/utrn / mice, for which no signiﬁcant diﬀerence
was found too [13]. However, one should keep in mind that
mdx/utrn +/ and / mice are much heavier and lighter
than mdx/utrn +/+ mice, respectively. This indicates that
the capacity for hypertrophy appears to be unaﬀected by
either partial or total utrophin deﬁciency. The diﬀerences
observed in central nucleation and muscle ﬁber size
probably also account to some degree for the reduced
performance in the mdx/utrn +/ and / mice, whichhave been described previously for mdx/utrn / mice
[14].
We also analyzed whether the bad motor performance
observed in the mdx/utrn +/ mice might be partly caused
by fatigability resulting from loss of acetylcholine receptors
at the NMJ due to the mono-allelic utrophin expression. In
mdx mice, the NMJ is remodelled in both its pre- and post-
synaptic components due to continuous cycles of re- and
degeneration [21,23]. Previous studies in utrn / and +/
mice, that do not have a behavioral or skeletal muscle
phenotype, revealed that the overall structure of their
NMJs is qualitatively normal [28,29]. NMJs of mdx/utrn
/ mice do not qualitatively diﬀer from those of mdx
mice, although in these mice re- and degeneration is more
pronounced [14,30]. We showed with a-bungarotoxin
staining of the diaphragm that neuromuscular synapses
of the mdx/utrn +/+, +/ and / mice have more punc-
tuate, discontinuous acetylcholine receptor area, while syn-
apses of wild type mice generally have an area of
continuous branches. Although our quantitative analysis
does not allow for detection of subtle distinctions between
the strains, we at least can conclude that massive acetylcho-
line receptor loss at the NMJ does not underlie muscle
weakness of mdx/utrn +/ mice. To elucidate whether
NMJ dysfunction contributes to fatigability of mdx/utrn
/ mice more detailed (physiological) investigation is
needed.
Expression levels of genes involved in regeneration,
inﬂammation and ﬁbrosis were tested in mice which under-
went the functional test regime and were sacriﬁced at an
age of 16 weeks as well as in non-exercised 6 weeks old
mice. For the older mice, a less pronounced trend was
observed, which might be caused by the age diﬀerence of
mdx/utrn / mice and the other strains. To test this,
expression was also assessed in young mice, revealing that
for all genes this was higher in mdx/utrn / mice com-
pared to age-matched mdx/utrn +/ and +/+ or C57BL/
10ScSnJ mice. The expression of the mdx/utrn +/ mice
was higher than that of the mdx/utrn +/+ mice for all
genes, although no signiﬁcant diﬀerence was found. Given
that the ﬁbrosis of mdx/utrn +/ mice worsens after
6 months we anticipate larger diﬀerence at later ages. How-
ever, this was beyond the scope of this study.
Additional factors that might result in bad motor func-
tion of the mdx/utrn +/ mice are i.e. behavioral, force
transmission and respiratory function related. Motor func-
tion tests performed in this study are not a reﬂection of a
sole neuromuscular defect, such as fatigue or strength,
but an integrated result of the whole body performance.
As such, outcomes are also inﬂuenced by behavioral and
coordination components, which might be altered in dys-
trophic mice to certain extents since both dystrophin and
utrophin are expressed in the central nervous system,
although expression does not overlap [31]. Mdx mice suﬀer
from behavioral abnormalities, however for mdx/utrn /
mice this is unknown, because behavioral studies are ham-
pered by their immobility and poor survival. Mice lacking
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least show no behavioral abnormalities [28,29].
To determine whether individual muscles suﬀer from
fatigue or loss of strength, experiments assessing e.g. spe-
ciﬁc forces and resistance to eccentric contractions should
be performed. Mdx mice have decreased speciﬁc forces
and resistance to eccentric contractions [26,32,33]. To
which extent the overall performance of the mdx/utrn
+/ mice is aﬀected by reduced muscle forces needs special
attention and should be monitored aside motor function
tests. In addition, the structure of the myotendinous junc-
tion, which is involved in force transmission from myoﬁ-
brils across the muscle membrane to the extracellular
matrix, might also play a role. The number of foldings in
this structure is reduced in mdx mice, but to a greater
extent in mdx/utrn / mice [13]. Future studies should
address this in the mdx/utrn +/ mice. Finally, decreased
respiratory function disables functional performance as
well. A recent paper indicates that respiratory function in
older (6 months) mdx/utrn +/ mice is impaired compared
to mdx mice, while no diﬀerence is found at the age of
3 months [16]. The mice used in this study might already
experience respiratory impairment resulting in a lower
functional performance. To which extent respiratory func-
tion disabled mdx/utrn +/ mice in their performance
needs to be further elucidated.
In conclusion, our ﬁndings indicate that mdx/utrn +/
mice have signiﬁcantly impaired functional performance
compared to mdx/utrn +/+ mice.Mdx/utrn +/ mice have
a high life expectancy and develop a more severe histopa-
thology when aging, which is already initiated at 4 months,
based on the increased mRNA muscle pathology biomark-
ers. This makes the mdx/utrn +/ mouse a better study
subject to determine the beneﬁts of potential therapeutic
compounds than the mdx/utrn / and mdx/utrn +/+
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